BACKGROUND:Anxiety disorders and pain are commonly comorbid, though little is known about the effect of pain on the course and treatment of anxiety. METHODS: This is a secondary analysis of a randomized controlled trial for anxiety treatment in primary care. Participants with panic disorder (PD) and/or generalized anxiety disorder (GAD) (N=191; 81% female, mean age 44) were randomized to either their primary-care physician's usual care or a 12-month course of telephone-based collaborative care. Anxiety severity, pain interference, health-related quality of life, health services use, and employment status were assessed at baseline, and at 2-, 4-, 8-, and 12-month follow-up. We defined response to anxiety treatment as a 40% or greater improvement from baseline on anxiety severity scales at 12-month follow-up. RESULTS: The 39% who reported high pain interference at baseline had more severe anxiety (mean SIGH-A score: 21.8 versus 18.0, P<.001), greater limitations in activities of daily living, and more work days missed in the previous month (5.8 versus 4.0 days, P=.01) than those with low pain interference. At 12-month follow-up, high pain interference was associated with a lower likelihood of responding to anxiety treatment (OR=.28; 95% CI=.12-.63) and higher health services use (26.1% with >/=1 hospitalization versus 12.0%, P<.001). CONCLUSIONS: Pain that interferes with daily activities is prevalent among primary care patients with PD/GAD and associated with more severe anxiety, worse daily functioning, higher health services use, and a lower likelihood of responding to treatment for PD/GAD. (c) 2009 Wiley-Liss, Inc.
RCT Entities:
BACKGROUND:Anxiety disorders and pain are commonly comorbid, though little is known about the effect of pain on the course and treatment of anxiety. METHODS: This is a secondary analysis of a randomized controlled trial for anxiety treatment in primary care. Participants with panic disorder (PD) and/or generalized anxiety disorder (GAD) (N=191; 81% female, mean age 44) were randomized to either their primary-care physician's usual care or a 12-month course of telephone-based collaborative care. Anxiety severity, pain interference, health-related quality of life, health services use, and employment status were assessed at baseline, and at 2-, 4-, 8-, and 12-month follow-up. We defined response to anxiety treatment as a 40% or greater improvement from baseline on anxiety severity scales at 12-month follow-up. RESULTS: The 39% who reported high pain interference at baseline had more severe anxiety (mean SIGH-A score: 21.8 versus 18.0, P<.001), greater limitations in activities of daily living, and more work days missed in the previous month (5.8 versus 4.0 days, P=.01) than those with low pain interference. At 12-month follow-up, high pain interference was associated with a lower likelihood of responding to anxiety treatment (OR=.28; 95% CI=.12-.63) and higher health services use (26.1% with >/=1 hospitalization versus 12.0%, P<.001). CONCLUSIONS:Pain that interferes with daily activities is prevalent among primary care patients with PD/GAD and associated with more severe anxiety, worse daily functioning, higher health services use, and a lower likelihood of responding to treatment for PD/GAD. (c) 2009 Wiley-Liss, Inc.
Authors: M K Shear; J Vander Bilt; P Rucci; J Endicott; B Lydiard; M W Otto; M H Pollack; L Chandler; J Williams; A Ali; D M Frank Journal: Depress Anxiety Date: 2001 Impact factor: 6.505
Authors: James M Russell; Risa Weisberg; Maurizio Fava; James T Hartford; Janelle S Erickson; Deborah N D'Souza Journal: Depress Anxiety Date: 2008 Impact factor: 6.505
Authors: Julia Davidoff; Scott Christensen; David N Khalili; Jaidyn Nguyen; Waguih William IsHak Journal: Qual Life Res Date: 2011-09-21 Impact factor: 4.147
Authors: Alexandre J Parent; Nicolas Beaudet; Hélène Beaudry; Jenny Bergeron; Patrick Bérubé; Guy Drolet; Philippe Sarret; Louis Gendron Journal: Behav Brain Res Date: 2012-01-08 Impact factor: 3.332
Authors: Natalia E Morone; Bea Herbeck Belnap; Fanyin He; Sati Mazumdar; Debra K Weiner; Bruce L Rollman Journal: J Gen Intern Med Date: 2012-08-10 Impact factor: 5.128
Authors: Peter Roy-Byrne; Mark D Sullivan; Cathy D Sherbourne; Daniela Golinelli; Michelle G Craske; Greer Sullivan; Murray B Stein Journal: Clin J Pain Date: 2013-09 Impact factor: 3.442
Authors: Natalia E Morone; Bea Belnap Herbeck; Yan Huang; Kaleab Z Abebe; Bruce L Rollman; Charles R Jonassaint Journal: Psychosom Med Date: 2021 Nov-Dec 01 Impact factor: 4.312